News and Accolades
Scientists in the Division of PACCSM Discover New Cellular Driver of Pulmonary Fibrosis
In the Nature Communications study led by Melanie Königshoff, MD, PhD, lysyl oxidase was shown to fuel scarring with an existing drug serving as a new potential treatment.
VMI Researchers Develop Groundbreaking Antidote for Carbon Monoxide Poisoning
Research led by Jesus Tejero, PhD, has found that a novel protein therapy, RcoM-HBD-CCC, clears CO from the bloodstream faster than current treatments, with potential for use by first responders in the field.
New Study by Dr. Frank Sciurba et al. Shows Promising Results for COPD Treatment
A new study led by Dr. Frank Sciurba, published in The New England Journal of Medicine, reveals that mepolizumab can significantly reduce exacerbations in COPD patients with eosinophilic inflammation—affecting up to 40% of those with the disease.